R&D is an expensive undertaking…especially for certain industries such as bio-sciences or pharmaceuticals. But sometimes your know-how, such as an R&D process, can turn into a licensable (and valuable) intellectual property that others can use to develop their IP.
One example is a small pharmaceutical company, who licenses its antibody R&D platform to other drug companies. In return for rights to use the R&D platform, licensees pay fees to use it and royalties on sales from each product incorporating its antibody technology.
Deciding when to license your intellectual property is always a question. License your IP too early and no one is interested. License it too late and the market is shifted in a new direction. Your intellectual property goes through a life cycle. First it’s created, then it moves into development, then […]
The quality of the teachers course content (IP) is becoming the value of the education.
If you’re an intellectual property owner who is not familiar with the licensing process or you don’t want to manage your own licensing program, then you should use a licensing agent. Although an agent adds to the cost of a licensing program, they bring experience, know-how and resources.
Commercializing IP is the process of transforming it from an intangible asset into a tangible product or service. You have 3 options for commercializing your IP: Sell, Make or License.